Par Technology Corporation Stock Price Today (NSE: PAR)
Fundamental Score
Par Technology Corporation Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Par Technology Corporation share price today is ₹89.47, up +0.18% on NSE/BSE as of 18 June 2026. Par Technology Corporation (PAR) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹110.69 (Cr). The 52-week high for PAR share price is ₹122.43 and the 52-week low is ₹78.05. At a P/E ratio of 11.42x, PAR is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 13.62% and a debt-to-equity ratio of 0.00.
Par Technology Corporation Share Price Chart — NSE/BSE Historical Performance
Par Technology Corporation share price chart: -1.66% return over the past month. 52-week high ₹122.43, 52-week low ₹78.05.
Par Technology Corporation — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹91.70 | ₹91.70 | ₹86.10 | ₹89.47 | 4.84K (Cr) | |
| ₹89.09 | ₹92.00 | ₹88.20 | ₹89.31 | 5.56K (Cr) | |
| ₹90.27 | ₹92.00 | ₹89.00 | ₹89.09 | 3.04K (Cr) | |
| ₹92.30 | ₹92.77 | ₹88.67 | ₹90.27 | 7.95K (Cr) | |
| ₹93.89 | ₹93.89 | ₹90.60 | ₹92.30 | 7.97K (Cr) | |
| ₹88.00 | ₹98.00 | ₹85.10 | ₹92.27 | 52.55K (Cr) | |
| ₹85.39 | ₹88.00 | ₹83.17 | ₹86.38 | 10.89K (Cr) | |
| ₹86.98 | ₹86.98 | ₹81.00 | ₹83.27 | 9.45K (Cr) | |
| ₹87.30 | ₹87.30 | ₹84.60 | ₹84.94 | 6.90K (Cr) | |
| ₹85.00 | ₹88.80 | ₹84.50 | ₹85.50 | 11.21K (Cr) |
Par Technology Corporation — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹89.09 | ₹92.00 | ₹86.10 | ₹89.47 | +0.43% | |
| ₹90.83 | ₹98.00 | ₹81.00 | ₹89.09 | -1.92% | |
| ₹78.58 | ₹95.55 | ₹78.58 | ₹90.83 | +15.59% | |
| ₹91.90 | ₹95.48 | ₹78.05 | ₹78.58 | -14.49% | |
| ₹91.40 | ₹105.05 | ₹88.10 | ₹95.69 | +4.69% | |
| ₹101.00 | ₹104.00 | ₹82.80 | ₹89.58 | -11.31% | |
| ₹89.00 | ₹114.00 | ₹84.00 | ₹101.26 | +13.78% | |
| ₹103.00 | ₹104.99 | ₹89.10 | ₹89.53 | -13.08% | |
| ₹102.60 | ₹109.50 | ₹98.70 | ₹102.17 | -0.42% | |
| ₹97.98 | ₹122.43 | ₹95.00 | ₹104.72 | +6.88% | |
| ₹100.59 | ₹105.04 | ₹90.81 | ₹96.41 | -4.16% | |
| ₹94.00 | ₹117.90 | ₹92.70 | ₹102.65 | +9.20% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Par Technology Corporation Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Par Technology Corporation Fundamental Analysis & Valuation Benchmarking
Educational evaluation of PAR across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Excellent ROCE Performance (18.35%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.67%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 11.42 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (12.57% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (21.53% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (21.54% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (131.90x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹51.44 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (73.37%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-51.98%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-17.31%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Par Technology Corporation vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Par Technology Corporation with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
60.4/100 | ₹89.47₹89 | ₹110.69₹110.69 | 11.42Average 11.4 Average | 13.62%Average 13.62% Average | 18.35%Good 18.35% Good | 0.00Excellent 0.0 Excellent | 21.54%Excellent 21.54% Excellent | 12.57%Good 12.57% Good | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Par Technology Corporation PE Ratio History
Historical price-to-earnings ratio for PAR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹10.86 | ₹101.26 | 9.3x |
| FY 2024 | ₹11.78 | ₹198.90 | 16.9x |
| FY 2023 | ₹9.21 | ₹215.70 | 23.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Par Technology Corporation Dividend History
Annual cash dividends paid by PAR — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2022 | ₹1.54 Cr |
| FY 2021 | ₹0.77 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Par Technology Corporation Quarterly Performance
Latest quarterly metrics for PAR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-17.31%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-51.98%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
12.57%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
21.54%
Compounded annual net profit growth over 5 years
Par Technology Corporation Technical Indicators
SMA 50, SMA 200, RSI and volume signals for PAR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Par Technology Corporation Financial Statements
Annual income statement, balance sheet and cash flow for Par Technology Corporation (PAR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Par Technology Corporation
About PAR (Par Technology Corporation)
Par Technology Corporation is a multifaceted technology company that, while not directly involved in pharmaceutical development or manufacturing, provides crucial technological inf...rastructure and services that are increasingly vital to the pharmaceutical industry. In this sector, PAR focuses on equipping pharmaceutical companies with advanced point-of-sale (POS) systems, data analytics platforms, and integrated software solutions designed to streamline operations, enhance customer engagement, and optimize supply chain management. This includes solutions for inventory management, tracking patient information securely, and supporting pharmaceutical retail operations at pharmacies, clinics, and healthcare facilities. PAR's technology offers the tools for pharmaceutical organizations to efficiently manage dispensing operations, comply with regulatory requirements, and improve patient experience at the point of care. PAR supports the pharmaceutical industry through its comprehensive suite of services geared towards boosting operational efficiency, which include supply chain optimization, regulatory compliance, and data-driven decision-making. The company provides analytical tools that enable pharmaceutical companies to monitor drug sales trends, forecast demand, and identify areas for improvement in their distribution networks. PAR's software helps to ensure that pharmaceutical operations are compliant with ever-evolving regulations, minimizing the risk of penalties and maintaining consumer trust. By leveraging PAR's technological prowess, pharmaceutical companies can navigate the complex landscape of healthcare regulations and optimize their processes from manufacturing to distribution. Finally, PAR’s contributions to the pharmaceutical sector extend into enhancing patient engagement and satisfaction. The company’s POS and data analytics solutions enable pharmacies and healthcare providers to offer personalized services, improve customer loyalty, and gather valuable feedback for continuous improvement. PAR also emphasizes data security and privacy, ensuring that patient information is handled with the utmost care and compliant with healthcare regulations. By leveraging PAR's innovative technologies, pharmaceutical organizations can better understand their patients' needs, deliver targeted healthcare services, and ultimately improve health outcomes while maintaining the highest standards of security and compliance.
Company Details
Key Leadership
Corporate Events
Latest News
PAR Share Price: Frequently Asked Questions
What is the current share price of Par Technology Corporation?
Par Technology Corporation (PAR) trades at ₹89.47 on NSE. Market cap ₹110.69 (Cr). Educational data only.
What is the P/E ratio of Par Technology Corporation?
Par Technology Corporation has a P/E of 11.42x vs industry average 31.77x.
What is the Bull Run score for Par Technology Corporation?
Par Technology Corporation has a Bull Run score of 60.4/100 based on 25+ financial parameters.
Does Par Technology Corporation pay dividends?
Par Technology Corporation has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Par Technology Corporation?
Par Technology Corporation has ROE of 13.62%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Par Technology Corporation?
Par Technology Corporation has debt-to-equity of 0.00.
Is Par Technology Corporation a good investment?
Bull Run gives Par Technology Corporation a score of 60.4/100. This is not investment advice — consult a SEBI-registered advisor.